Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 6943-6954

  Roviš, Tihana Lenac ^a   Bailer, Susanne M ^b,c   Pothineni, Venkata R ^b   Ouwendijk, Werner J D ^d   Šimić, Hrvoje ^a   Babić, Marina ^a   Miklić, Karmela ^a   Malić, Suzana ^a   Verweij, Marieke C ^e   Baiker, Armin ^b,f   Gonzalez, Orland ^b   Brunn, Albrecht von ^b   Zimmer, Ralf ^b   Früh, Klaus ^e   Verjans, Georges M G M ^d   Jonjić, Stipan ^a   Haasb, Jürgeni ^g  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Bavarian Health and Food Safety Authority   (Germany)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS REACTION; FEMALE; GENE EXPRESSION; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN DEFECT; VARICELLA ZOSTER VIRUS; VIRUS PATHOGENESIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CHICKENPOX; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MICE; MICE, INBRED BALB C; PROTEOMICS; SKIN; VIRAL PROTEINS;

CERCOPITHECINE HERPESVIRUS 9; HUMAN HERPESVIRUS 3; PRIMATES; SAL VIEJA VIRUS;

EID: 84878552793     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00407-13     Document Type: Article

References (56)

1. Arvin AM. 1996. Varicella-zoster virus. Clin. Microbiol. Rev. 9:361-381.
2. Arvin AM. 2001. Varicella-zoster virus: molecular virology and virus-host interactions. Curr. Opin. Microbiol. 4:442-449.
3. Moffat J, Ku CC, Zerboni L, Sommer M, Arvin A. 2007. VZV:pathogenesis and the disease consequences of primary infection, p 675-688. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, FIG 7 Cross-reactivity of VZV-specific antibodies with SVV proteins in Western blots. (A) To determine if the VZV-specific MAbs recognized SVV proteins, protein lysates were generated from mock-and SVV-infected monkey cells at 48 h postinfection and analyzed by Western blotting using MAbs raised against the indicated VZV ORFs. Molecular mass markers (in kDa) are shown on the left. (B) Synthetic peptides covering the domain of ORF31/gB (residues 814 to 931) and ORF60/gL (residues 37 to 160, shown together with its interacting glycoprotein gH), previously used as immunogens, were synthesized as 15-mers with an offset of 3 residues and coupled to cellulose membranes. Membranes were incubated with ORF-specific antibodies. The topology of these membrane proteins is depicted graphically; the sequence of reactive peptides is shown in red. The epitope region identified in VZV ORF31/gB and ORF60/gL (top) is aligned with the amino acid sequence of the respective ORF31 and ORF60 of SVV (bottom). Asterisks represent conserved but not identical amino acids. Lenac Roviš et al. Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
4. Cohen JI. 2007. VZV: molecular basis of persistence (latency and reactivation), p 689-699. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
5. Arvin A, Abendroth A. 2007. VZV: immunobiology and host response, p 700-712. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, YamanishiK(ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
6. Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. 2011. The neurobiology of varicella zoster virus infection. Neuropathol. Appl. Neurobiol 37:441-463.
7. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragon MV, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E. 2007. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25:7866-7872.
8. Gershon AA. 2007. Varicella-zoster vaccine, p 1262-1273. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
9. Roizman B, Campadelli-Fiume G. 2007. Alphaherpes viral genes and their functions, p 70-92. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
10. Cohen JI. 2010. The varicella-zoster virus genome. Curr. Top. Microbiol. Immunol. 342:1-14.
11. Baines JD, Pellett PE. 2007. Genetic comparison of human alphaherpesvirus genomes, p 61-69. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
12. Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, Cheng T, Xia N, Zhu H. 2010. Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog. 6:e1000971. doi:10.1371/journal.ppat.1000971.
13. Kaufer BB, Smejkal B, Osterrieder N. 2010. The varicella-zoster virus ORFS/L (ORF0) gene is required for efficient viral replication and contains an element involved in DNA cleavage. J. Virol. 84:11661-11669.
14. Chen JJ, Zhu Z, Gershon AA, Gershon MD. 2004. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 119:915-926.
15. Myers MG, Connelly BL. 1992. Animal models of varicella. J. Infect. Dis. 166(Suppl 1):S48-S50.
16. Ku CC, Besser J, Abendroth A, Grose C, Arvin AM. 2005. Varicellazoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J. Virol. 79:2651-2658.
17. Gray WL. 2010. Simian varicella virus: molecular virology. Curr. Top. Microbiol. Immunol. 342:291-308.
18. Gray WL, Mullis LB, Soike KF. 2001. Expression of the simian varicella virus glycoprotein E. Virus Res. 79:27-37.
19. Messaoudi I, Barron A, Wellish M, Engelmann F, Legasse A, Planer S, Gilden D, Nikolich-Zugich J, Mahalingam R. 2009. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog. 5:e1000657. doi:10.1371/journal.ppat.1000657.
20. Uetz P, Dong YA, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J. 2006. Herpesviral protein networks and their interaction with the human proteome. Science 311: 239-242.
21. Cagney G, Uetz P, Fields S. 2000. High-throughput screening for protein-protein interactions using two-hybrid assay. Methods Enzymol. 328: 3-14.
22. Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, Bandyopadhyay S, Rose D, von Brunn A, Uhlmann M, Zeretzke C, Dong YA, Boulet H, Koegl M, Bailer SM, Koszinowski U, Ideker T, Uetz P, Zimmer R, Haas J. 2009. Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog. 5:e1000570. doi:10.1371/journal.ppat.1000570.
23. Stellberger T, Hauser R, Baiker A, Pothineni VR, Haas J, Uetz P. 2010. Improving the yeast two-hybrid system with permutated fusions proteins: the varicella zoster virus interactome. Proteome Sci. 8:8. doi:10.1186/1477-5956-8-8.
24. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. 1974. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet ii:1288.
25. Schmidt-Chanasit J, Bleymehl K, Rabenau HF, Ulrich RG, Cinatl J, Jr, Doerr HW. 2008. In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J. Clin. Microbiol. 46:2122-2124.
26. Harper DR, Mathieu N, Mullarkey J. 1998. High-titre, cryostable cellfree varicella zoster virus. Arch. Virol. 143:1163-1170.
27. Mahalingam R, Wellish M, White T, Soike K, Cohrs R, Kleinschmidt-DeMasters BK, Gilden DH. 1998. Infectious simian varicella virus expressing the green fluorescent protein. J. Neurovirol. 4:438-444.
28. Ott M, Tascher G, Hassdenteufel S, Zimmermann R, Haas J, Bailer SM. 2011. Functional characterization of the essential tail anchor of the herpes simplex virus type 1 nuclear egress protein pUL34. J. Gen. Virol. 92:2734-2745.
29. Remeijer L, Duan R, van Dun JM, Wefers Bettink MA, Osterhaus AD, Verjans GM. 2009. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J. Infect. Dis. 200:11-19.
30. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus AD. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.
31. Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C. 2001. Varicellazoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289:218-223.
32. Reddy SM, Cox E, Iofin I, Soong W, Cohen JI. 1998. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72:8083-8088.
33. Koshizuka T, Sadaoka T, Yoshii H, Yamanishi K, Mori Y. 2008. Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells. Virology 377:289-295.
34. Cox E, Reddy S, Iofin I, Cohen JI. 1998. Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 250:205-209.
35. Nuovo GJ. 2006. The surgical and cytopathology of viral infections: utility of immunohistochemistry, in situ hybridization, and in situ polymerase chain reaction amplification. Ann. Diagn. Pathol. 10:117-131.
36. Muraki R, Baba T, Iwasaki T, Sata T, Kurata T. 1992. Immunohistochemical study of skin lesions in herpes zoster. Virchows Arch. A Pathol. Anat. Histopathol. 420:71-76.
37. Ouwendijk WJ, Flowerdew SE, Wick D, Horn AK, Sinicina I, Strupp M, Osterhaus AD, Verjans GM, Hufner K. 2012. Immunohistochemical detection of intra-neuronalVZVproteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens.J. Neurovirol. 18:172-180.
38. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Pierard GE. 1995. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use. J. Med. Virol. 47:342-347.
39. Huch JH, Cunningham AL, Arvin AM, Nasr N, Santegoets SJ, Slobedman E, Slobedman B, Abendroth A. 2010. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J. Virol. 84:4060-4072.
40. Fan Q, Lin E, Spear PG. 2009. Insertional mutations in herpes simplex virus type 1 gL identify functional domains for association with gH and for membrane fusion. J. Virol. 83:11607-11615.
41. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L. 2008. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog. 4:e1000100. doi:10.1371/journal.ppat.1000100.
42. Sander G, Konrad A, Thurau M, Wies E, Leubert R, Kremmer E, Dinkel H, Schulz T, Neipel F, Sturzl M. 2008. Intracellular localization map of human herpesvirus 8 proteins. J. Virol. 82:1908-1922.
43. Reichelt M, Brady J, Arvin AM. 2009. The replication cycle of varicellazoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J. Virol. 83:3904-3918.
44. Sato H, Pesnicak L, Cohen JI. 2002. Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J. Virol. 76:3575-3578.
45. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618.
46. Govero J, Hall S, Heineman TC. 2007. Intracellular localization of varicella-zoster virus ORF39 protein and its functional relationship to glycoprotein K. Virology 358:291-302.
47. Hall SL, Govero JL, Heineman TC. 2007. Intracellular transport and stability of varicella-zoster virus glycoprotein K. Virology 358:283-290.
48. Mo C, Suen J, Sommer M, Arvin A. 1999. Characterization of varicellazoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol. 73:4197-4207.
49. Grose C, Carpenter JE, Jackson W, Duus KM. 2010. Overview of varicella-zoster virus glycoproteins gC, gH and gL. Curr. Top. Microbiol. Immunol. 342:113-128.
50. Vleck SE, Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM. 2010. Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model. J. Virol. 84:141-152.
51. Chowdary TK, Cairns TM, Atanasiu D, Cohen GH, Eisenberg RJ, Heldwein EE. 2010. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat. Struct. Mol. Biol. 17:882-888.
52. Birlea M, Owens GP, Eshleman EM, Ritchie A, Traktinskiy I, Bos N, Seitz S, Yevgeniy A, Mahalingam R, Gilden D, Cohrs RJ. 2013. Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes gH/gL complex and neutralizes VZV infection. J. Virol. 87:415-421.
53. Mahalingam R, Gilden DH. 2007. Simian varicella virus, p 1043-1050. In Arvin A, Campadelli-Fiume G, Mocarski E,MoorePS, Roizman B, Whitley R, YamanishiK(ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
54. Gray WL, Starnes B, White MW, Mahalingam R. 2001. The DNA sequence of the simian varicella virus genome. Virology 284:123-130.
55. Ashburn CV, Gray WL. 2002. Expression of the simian varicella virus glycoprotein L and H. Arch. Virol. 147:335-348.
56. Mueller NH, Bos NL, Seitz S, Wellish M, Mahalingam R, Gilden D, Cohrs RJ. 2012. Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein. J. Virol. 86: 6345-6349